Cookson Peirce & Co. Inc. Boosts Stock Position in Cigna Group $CI

Cookson Peirce & Co. Inc. boosted its holdings in Cigna Group (NYSE:CI) by 74.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,912 shares of the health services provider’s stock after purchasing an additional 2,094 shares during the period. Cookson Peirce & Co. Inc.’s holdings in Cigna Group were worth $1,624,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Flaharty Asset Management LLC purchased a new position in Cigna Group in the first quarter worth $28,000. 1248 Management LLC purchased a new position in shares of Cigna Group during the 1st quarter valued at $29,000. Activest Wealth Management lifted its position in shares of Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after buying an additional 72 shares during the last quarter. Princeton Global Asset Management LLC lifted its position in shares of Cigna Group by 115.6% during the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after buying an additional 52 shares during the last quarter. Finally, Retirement Wealth Solutions LLC lifted its position in shares of Cigna Group by 74.1% during the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock valued at $33,000 after buying an additional 43 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $308.30 on Thursday. The firm has a market capitalization of $82.30 billion, a P/E ratio of 16.83, a P/E/G ratio of 0.90 and a beta of 0.45. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock’s 50-day simple moving average is $298.83 and its two-hundred day simple moving average is $307.81. Cigna Group has a twelve month low of $256.89 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the company earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio is currently 32.97%.

Analyst Ratings Changes

A number of brokerages have recently commented on CI. The Goldman Sachs Group began coverage on Cigna Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $370.00 price target on the stock. Truist Financial set a $375.00 price objective on Cigna Group in a report on Tuesday, September 2nd. Barclays increased their price objective on Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Royal Bank Of Canada reissued an “outperform” rating and set a $371.00 price objective on shares of Cigna Group in a report on Thursday, June 26th. Finally, Wall Street Zen cut Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, October 3rd. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $369.89.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This represents a 9.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is owned by corporate insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.